Stocksigma LogoStocksigma Logo

Vanta Bioscience Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs)

■ Revenue: 151 (+363.9% YoY | +401.9% QoQ) ■ EBITDA: 139 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 91.6 (Loss to Profit YoY | Loss to

Vanta Bioscience Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs)

Vanta Bioscience Ltd · Outcome · 31 May 2026, 1:55 am

Vanta Bioscience Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 151 (+363.9% YoY | +401.9% QoQ) ■ EBITDA: 139 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 91.6 (Loss to Profit YoY | Loss to Profit QoQ) ■ PAT: 193 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 2.71 (Loss to Profit YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Vanta Bioscience Ltd

All Vanta Bioscience Ltd announcements